BPC-157 vs NAD+: Which Belongs in Your Protocol?
BPC-157 and NAD+ are two of the most powerful tools in modern regenerative medicine — but they work through completely different mechanisms and address different problems. Understanding when to use each, and when to combine them, can make a significant difference in your results.
The core difference
BPC-157 is a tissue repair and healing peptide. NAD+ is a cellular energy and longevity coenzyme. These are not competing therapies — they operate at different levels of biology. BPC-157 accelerates the repair of specific tissues and structures: tendons, ligaments, gut lining, muscles. NAD+ addresses cellular energy production and aging at the mitochondrial and genomic level.
The best answer is often both: Many longevity and functional medicine protocols combine BPC-157 (for acute or structural healing) with NAD+ (for systemic cellular optimization). They are highly complementary rather than alternatives to each other. The question is typically which to prioritize first based on your primary goals.
BPC-157: overview
BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in human gastric juice. Researchers have studied it since the 1990s primarily for its remarkable healing properties: accelerated tendon and ligament repair, gut healing, anti-inflammatory effects, and neuroprotection. It works by stimulating angiogenesis, upregulating growth hormone receptors, and activating nitric oxide pathways at sites of injury.
BPC-157 is most valuable when there is something specific to heal or repair — an injury, a gut condition, joint inflammation, or muscle damage. It is the most directly therapeutic of the two for acute, localized conditions. Read our full BPC-157 guide and dosage guide.
NAD+: overview
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell of the body. It is essential for mitochondrial energy production, DNA repair, and the activation of sirtuins — longevity proteins that regulate aging, stress responses, and metabolism. NAD+ levels decline by ~50% between ages 40 and 60, contributing to the fatigue, cognitive decline, and metabolic slowdown associated with aging.
NAD+ therapy is most valuable when the primary goals are energy restoration, cognitive enhancement, anti-aging, or systemic metabolic optimization. It is a foundational longevity tool rather than a targeted healing compound. Read our full NAD+ guide.
Side by side comparison
| Feature | BPC-157 | NAD+ |
|---|---|---|
| Category | Healing peptide | Cellular coenzyme / longevity therapy |
| Primary target | Injured/damaged tissues | Mitochondria, DNA, sirtuins |
| Best for | Injury recovery, gut health, inflammation | Energy, anti-aging, cognitive function |
| Mechanism | Angiogenesis, GH receptor upregulation, NO pathway | Electron transport chain, PARP, sirtuin activation |
| Administration | Subcutaneous injection or oral | IV infusion, injection, or oral precursors |
| Speed of results | Days to weeks (injury dependent) | Hours to days (energy), months (longevity) |
| Side effects | Minimal; occasional nausea | IV: flushing, chest tightness if too fast |
| Monthly cost | $150–$300 (injection) | $200–$600 (IV monthly) / $100–$200 (injection) |
| Legal status | Legal research peptide | Legal; widely available |
| Stack well together? | Yes — highly complementary | Yes — highly complementary |
Cost comparison
BPC-157 injection protocols typically run $150–$300 per month through a compounding pharmacy. Oral BPC-157 capsules are somewhat less expensive. NAD+ IV infusions cost $200–$600 per session, with most maintenance protocols requiring monthly infusions. Injectable NAD+ is less expensive at $100–$200 per month.
When stacked together, the combined monthly investment for both BPC-157 and injectable NAD+ typically runs $300–$500. For patients who want both acute healing and systemic optimization — which is most longevity-focused patients — this combination is considered excellent value relative to the results it produces.
Note: Both compounds benefit from clinical oversight. BPC-157 should be sourced from a licensed US compounding pharmacy. NAD+ IV therapy should be administered by a qualified medical professional.
Find a clinic near you
Ready to start peptide therapy? Tides connects you with vetted clinics across the US:
Don’t see your city? Join the waitlist and we will notify you when a vetted clinic is available near you.